+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Crohn Disease Drug"

Crohn's Disease (CD) Treatment Global Market Report 2024 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Crohn's Disease Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Crohn's Disease Epidemiology Analysis and Forecast to 2032

  • Report
  • August 2023
  • 47 Pages
  • Global
From
From
From
Crohn's Disease - Pipeline Insight, 2021 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2021

  • Clinical Trials
  • May 2021
  • 150 Pages
  • Global
From
Crohn's Disease (CD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Crohn's Disease (CD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
US Crohn's Disease Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Crohn's Disease Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
Crohn's Disease - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Crohn's Disease - Global Drug Forecast and Market Analysis to 2029

  • Report
  • September 2020
  • 148 Pages
  • Global
From
Crohn's Disease - Epidemiology Forecast to 2029 - Product Thumbnail Image

Crohn's Disease - Epidemiology Forecast to 2029

  • Report
  • September 2020
  • 47 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2019 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2019

  • Clinical Trials
  • December 2019
  • 901 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 Pages
  • Global
From
From
Loading Indicator

Crohn Disease is a chronic inflammatory disorder of the gastrointestinal tract, and is one of the most common immune disorders. Treatment for Crohn Disease typically involves a combination of medications, lifestyle changes, and in some cases, surgery. Common medications used to treat Crohn Disease include corticosteroids, immunomodulators, biologic therapies, and antibiotics. Corticosteroids are used to reduce inflammation, while immunomodulators are used to suppress the immune system. Biologic therapies are used to target specific proteins in the body that are involved in the inflammatory process, and antibiotics are used to treat bacterial infections. The Crohn Disease Drug market is a rapidly growing segment of the Immune Disorders Drugs market. It is driven by the increasing prevalence of Crohn Disease, as well as the development of new and innovative treatments. Companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Pfizer, and UCB. Show Less Read more